Back to publication

Effect of Escalating Financial Incentive Rewards on Maintenance of Weight Loss

Assessed by RV001 · Medical statistician

Assessed on 31 Oct 2025

OverallReviewer's overall integrity assessment, derived from all research questions No concerns

DOI 10.1001/jamanetworkopen.2019.14393 (opens in new tab)

Resource ripekg:research-integrity-assessment/RIPEAF6F62EBFADD42DFB

5 Research Questions · 3 Evidence Items

Q1.1 — Does the study have an associated retraction?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Q1.3 — Do other studies by the research team highlight causes for concern?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: Although a correction has been flagged, this relates to the failure to acknowledge a particular individual and is not related to the integrity of the study results.

Supporting Evidence (1)

Retraction NoticeSource: Retraction Watch database

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

10.1056/nejmx160005 (opens in new tab)
Journal: NEJM: The New England Journal of MedicinePublisher: Massachusetts Medical SocietyDate: 10 Mar 2016

RetractionWatch ID:Record identifier in the Retraction Watch database 9053

Rationale: Concerns/Issues about Referencing/Attributions;Error in Text;Legal Reasons and/or Threats

About Author: Pamela Shaw

Q2.2 — Are there concerns relating to the timing or absence of study registration?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Supporting Evidence (2)

Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)

Registration ID: NCT01900392

Registry: ClinicalTrials.gov

Registry Link: https://clinicaltrials.gov/study/NCT01900392 (opens in new tab)

Registration Date: 11-07-2013

Prospective:Whether the trial was registered before participant recruitment began Yes

Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registration date is on or before LLM recruitment start date.

Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text

Recruitment Start: 23-05-2016

Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Methods: 'Recruitment for the study began May 23, 2016' based on intention to treat.

Recruitment End: 13-11-2016

Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date Methods: 'Recruitment for the study ended November 13, 2016, when target sample size was reached' based on intention to treat.

Study End: 13-11-2017

Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date Methods: 'with the final participant completing the follow-up period on November 13, 2017' based on intention to treat.

Overall — What is the overall integrity assessment of the study?

Automated Assessment:Assessment produced by the automated systemN/A
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo concerns

Rationale: Although a correction has been flagged, this relates to the failure to acknowledge a particular individual and is not related to the integrity of the study results.